Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Advair Diskus versus Flovent Diskus in pediatric asthma during the fall viral season
2015-004887-13Phase 4
- Sponsor
- GSK
- Start
- Dec 2016
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in asthma comparing Advair Diskus twice daily with Flovent Diskus twice daily (2 arms). Primary endpoints: Number of asthma exacerbations during the double-blind treatment period and Time-adjusted relative risk of having an exacerbation.
02
Drugs
salmeterol + fluticasonefluticasone propionate nasal spray
03
Conditions
asthma
Beyond the preview
Go deeper on 2015-004887-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-004887-13.